Loading…
Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression
Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize the mitochondrial morphology and attenuate mitochondrial malfunction in both KKAy mice and...
Saved in:
Published in: | Journal of cellular physiology 2017-10, Vol.232 (10), p.2776-2787 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03 |
---|---|
cites | cdi_FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03 |
container_end_page | 2787 |
container_issue | 10 |
container_start_page | 2776 |
container_title | Journal of cellular physiology |
container_volume | 232 |
creator | Ni, Zheng Tao, Liang Xiaohui, Xu Zelin, Zhao Jiangang, Liu Zhao, Song Weikang, Huo Hongchao, Xu Qiujing, Wang Xin, Li |
description | Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize the mitochondrial morphology and attenuate mitochondrial malfunction in both KKAy mice and in hyperglycemia (HG)‐induced MPC5 cells. We use Western blot analysis to demonstrate that PD reversed podocyte apoptosis induced by HG via suppressing dynamin‐related protein 1 (Drp1). This effect may depend on the ability of PD to inhibit the generation of cellular reactive oxygen species (ROS). In conclusion, we demonstrate that PD may be therapeutically useful in DN, and that, podocyte apoptosis induced by HG can be reversed by PD through suppressing Drp1 expression.
Our findings provide new insights into the pathogenic process of HG‐induced podocyte injury and also identify a new therapeutic target of ROS/Drp1/mitochondrial fission/apoptosis pathway for diabetic nephropathy. |
doi_str_mv | 10.1002/jcp.25943 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5518182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1912663436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03</originalsourceid><addsrcrecordid>eNp1kc1O3DAURq0KVAbaRV-gssQGFmH8m9ibSmigBYRUFu3achwPeJTYwU6AvH1NM0VQidXV1T06-q4-AL5gdIIRIsuN6U8Il4x-AAuMZFWwkpMdsMg3XEjO8B7YT2mDEJKS0o9gjwgqaFXxBbA3oZ0aPTgPXddrFxPs3BDMXfBNdBqu3eBtSlD7BurOti5EPdgE-9AEMw0WOr8Z4wTrCaax72Nmnb-FZ7HH0D7Ne_CfwO5at8l-3s4D8Pv7-a_VRXH988fl6vS6MIxRWtC6kSVDuiIcYVnzmvBKI8ZxWWosBGuk1AaZWtQWMZtJSWpaGckE0YIZRA_At9nbj3VnG2P9EHWr-ug6HScVtFNvL97dqdvwoDjHAguSBUdbQQz3o02D6lwytm21t2FM6jmFqCQhOKOH_6GbMEaf31NYYlKWlNEyU8czZWJIKdr1SxiM1HN5Kpen_paX2a-v07-Q_9rKwHIGHl1rp_dN6mp1Myv_AMQYpTU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1912663436</pqid></control><display><type>article</type><title>Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Ni, Zheng ; Tao, Liang ; Xiaohui, Xu ; Zelin, Zhao ; Jiangang, Liu ; Zhao, Song ; Weikang, Huo ; Hongchao, Xu ; Qiujing, Wang ; Xin, Li</creator><creatorcontrib>Ni, Zheng ; Tao, Liang ; Xiaohui, Xu ; Zelin, Zhao ; Jiangang, Liu ; Zhao, Song ; Weikang, Huo ; Hongchao, Xu ; Qiujing, Wang ; Xin, Li</creatorcontrib><description>Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize the mitochondrial morphology and attenuate mitochondrial malfunction in both KKAy mice and in hyperglycemia (HG)‐induced MPC5 cells. We use Western blot analysis to demonstrate that PD reversed podocyte apoptosis induced by HG via suppressing dynamin‐related protein 1 (Drp1). This effect may depend on the ability of PD to inhibit the generation of cellular reactive oxygen species (ROS). In conclusion, we demonstrate that PD may be therapeutically useful in DN, and that, podocyte apoptosis induced by HG can be reversed by PD through suppressing Drp1 expression.
Our findings provide new insights into the pathogenic process of HG‐induced podocyte injury and also identify a new therapeutic target of ROS/Drp1/mitochondrial fission/apoptosis pathway for diabetic nephropathy.</description><identifier>ISSN: 0021-9541</identifier><identifier>EISSN: 1097-4652</identifier><identifier>DOI: 10.1002/jcp.25943</identifier><identifier>PMID: 28383775</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Animals ; Apoptosis ; Apoptosis - drug effects ; Blood Glucose - metabolism ; Cell Line ; Cytoprotection ; Diabetes mellitus ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - metabolism ; Diabetes Mellitus, Type 2 - pathology ; Diabetic Nephropathies - drug therapy ; Diabetic Nephropathies - etiology ; Diabetic Nephropathies - metabolism ; Diabetic Nephropathies - pathology ; Diabetic nephropathy ; Disease Models, Animal ; Down-Regulation ; Dynamin ; Dynamins - genetics ; Dynamins - metabolism ; dynamin‐related protein 1 ; Fitness ; Glucosides - pharmacology ; Hyperglycemia ; Mice, Inbred C57BL ; Mitochondria ; Mitochondria - drug effects ; Mitochondria - metabolism ; Mitochondria - pathology ; Mitochondrial Dynamics - drug effects ; Nephropathy ; Original ; Original s ; Podocytes - drug effects ; Podocytes - metabolism ; Podocytes - pathology ; polydatin ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Renal function ; Resveratrol ; Retarding ; RNA Interference ; Rodents ; Signal Transduction - drug effects ; Stilbenes - pharmacology ; Transfection</subject><ispartof>Journal of cellular physiology, 2017-10, Vol.232 (10), p.2776-2787</ispartof><rights>2017 The Authors. Published by Wiley Periodicals Inc.</rights><rights>2017 The Authors. Journal of Cellular Physiology Published by Wiley Periodicals Inc.</rights><rights>2017 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03</citedby><cites>FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03</cites><orcidid>0000-0001-7314-4249</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28383775$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ni, Zheng</creatorcontrib><creatorcontrib>Tao, Liang</creatorcontrib><creatorcontrib>Xiaohui, Xu</creatorcontrib><creatorcontrib>Zelin, Zhao</creatorcontrib><creatorcontrib>Jiangang, Liu</creatorcontrib><creatorcontrib>Zhao, Song</creatorcontrib><creatorcontrib>Weikang, Huo</creatorcontrib><creatorcontrib>Hongchao, Xu</creatorcontrib><creatorcontrib>Qiujing, Wang</creatorcontrib><creatorcontrib>Xin, Li</creatorcontrib><title>Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression</title><title>Journal of cellular physiology</title><addtitle>J Cell Physiol</addtitle><description>Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize the mitochondrial morphology and attenuate mitochondrial malfunction in both KKAy mice and in hyperglycemia (HG)‐induced MPC5 cells. We use Western blot analysis to demonstrate that PD reversed podocyte apoptosis induced by HG via suppressing dynamin‐related protein 1 (Drp1). This effect may depend on the ability of PD to inhibit the generation of cellular reactive oxygen species (ROS). In conclusion, we demonstrate that PD may be therapeutically useful in DN, and that, podocyte apoptosis induced by HG can be reversed by PD through suppressing Drp1 expression.
Our findings provide new insights into the pathogenic process of HG‐induced podocyte injury and also identify a new therapeutic target of ROS/Drp1/mitochondrial fission/apoptosis pathway for diabetic nephropathy.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Cell Line</subject><subject>Cytoprotection</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Diabetes Mellitus, Type 2 - pathology</subject><subject>Diabetic Nephropathies - drug therapy</subject><subject>Diabetic Nephropathies - etiology</subject><subject>Diabetic Nephropathies - metabolism</subject><subject>Diabetic Nephropathies - pathology</subject><subject>Diabetic nephropathy</subject><subject>Disease Models, Animal</subject><subject>Down-Regulation</subject><subject>Dynamin</subject><subject>Dynamins - genetics</subject><subject>Dynamins - metabolism</subject><subject>dynamin‐related protein 1</subject><subject>Fitness</subject><subject>Glucosides - pharmacology</subject><subject>Hyperglycemia</subject><subject>Mice, Inbred C57BL</subject><subject>Mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondria - pathology</subject><subject>Mitochondrial Dynamics - drug effects</subject><subject>Nephropathy</subject><subject>Original</subject><subject>Original s</subject><subject>Podocytes - drug effects</subject><subject>Podocytes - metabolism</subject><subject>Podocytes - pathology</subject><subject>polydatin</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Renal function</subject><subject>Resveratrol</subject><subject>Retarding</subject><subject>RNA Interference</subject><subject>Rodents</subject><subject>Signal Transduction - drug effects</subject><subject>Stilbenes - pharmacology</subject><subject>Transfection</subject><issn>0021-9541</issn><issn>1097-4652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kc1O3DAURq0KVAbaRV-gssQGFmH8m9ibSmigBYRUFu3achwPeJTYwU6AvH1NM0VQidXV1T06-q4-AL5gdIIRIsuN6U8Il4x-AAuMZFWwkpMdsMg3XEjO8B7YT2mDEJKS0o9gjwgqaFXxBbA3oZ0aPTgPXddrFxPs3BDMXfBNdBqu3eBtSlD7BurOti5EPdgE-9AEMw0WOr8Z4wTrCaax72Nmnb-FZ7HH0D7Ne_CfwO5at8l-3s4D8Pv7-a_VRXH988fl6vS6MIxRWtC6kSVDuiIcYVnzmvBKI8ZxWWosBGuk1AaZWtQWMZtJSWpaGckE0YIZRA_At9nbj3VnG2P9EHWr-ug6HScVtFNvL97dqdvwoDjHAguSBUdbQQz3o02D6lwytm21t2FM6jmFqCQhOKOH_6GbMEaf31NYYlKWlNEyU8czZWJIKdr1SxiM1HN5Kpen_paX2a-v07-Q_9rKwHIGHl1rp_dN6mp1Myv_AMQYpTU</recordid><startdate>201710</startdate><enddate>201710</enddate><creator>Ni, Zheng</creator><creator>Tao, Liang</creator><creator>Xiaohui, Xu</creator><creator>Zelin, Zhao</creator><creator>Jiangang, Liu</creator><creator>Zhao, Song</creator><creator>Weikang, Huo</creator><creator>Hongchao, Xu</creator><creator>Qiujing, Wang</creator><creator>Xin, Li</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7314-4249</orcidid></search><sort><creationdate>201710</creationdate><title>Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression</title><author>Ni, Zheng ; Tao, Liang ; Xiaohui, Xu ; Zelin, Zhao ; Jiangang, Liu ; Zhao, Song ; Weikang, Huo ; Hongchao, Xu ; Qiujing, Wang ; Xin, Li</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Cell Line</topic><topic>Cytoprotection</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Diabetes Mellitus, Type 2 - pathology</topic><topic>Diabetic Nephropathies - drug therapy</topic><topic>Diabetic Nephropathies - etiology</topic><topic>Diabetic Nephropathies - metabolism</topic><topic>Diabetic Nephropathies - pathology</topic><topic>Diabetic nephropathy</topic><topic>Disease Models, Animal</topic><topic>Down-Regulation</topic><topic>Dynamin</topic><topic>Dynamins - genetics</topic><topic>Dynamins - metabolism</topic><topic>dynamin‐related protein 1</topic><topic>Fitness</topic><topic>Glucosides - pharmacology</topic><topic>Hyperglycemia</topic><topic>Mice, Inbred C57BL</topic><topic>Mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondria - pathology</topic><topic>Mitochondrial Dynamics - drug effects</topic><topic>Nephropathy</topic><topic>Original</topic><topic>Original s</topic><topic>Podocytes - drug effects</topic><topic>Podocytes - metabolism</topic><topic>Podocytes - pathology</topic><topic>polydatin</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Renal function</topic><topic>Resveratrol</topic><topic>Retarding</topic><topic>RNA Interference</topic><topic>Rodents</topic><topic>Signal Transduction - drug effects</topic><topic>Stilbenes - pharmacology</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ni, Zheng</creatorcontrib><creatorcontrib>Tao, Liang</creatorcontrib><creatorcontrib>Xiaohui, Xu</creatorcontrib><creatorcontrib>Zelin, Zhao</creatorcontrib><creatorcontrib>Jiangang, Liu</creatorcontrib><creatorcontrib>Zhao, Song</creatorcontrib><creatorcontrib>Weikang, Huo</creatorcontrib><creatorcontrib>Hongchao, Xu</creatorcontrib><creatorcontrib>Qiujing, Wang</creatorcontrib><creatorcontrib>Xin, Li</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ni, Zheng</au><au>Tao, Liang</au><au>Xiaohui, Xu</au><au>Zelin, Zhao</au><au>Jiangang, Liu</au><au>Zhao, Song</au><au>Weikang, Huo</au><au>Hongchao, Xu</au><au>Qiujing, Wang</au><au>Xin, Li</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression</atitle><jtitle>Journal of cellular physiology</jtitle><addtitle>J Cell Physiol</addtitle><date>2017-10</date><risdate>2017</risdate><volume>232</volume><issue>10</issue><spage>2776</spage><epage>2787</epage><pages>2776-2787</pages><issn>0021-9541</issn><eissn>1097-4652</eissn><abstract>Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize the mitochondrial morphology and attenuate mitochondrial malfunction in both KKAy mice and in hyperglycemia (HG)‐induced MPC5 cells. We use Western blot analysis to demonstrate that PD reversed podocyte apoptosis induced by HG via suppressing dynamin‐related protein 1 (Drp1). This effect may depend on the ability of PD to inhibit the generation of cellular reactive oxygen species (ROS). In conclusion, we demonstrate that PD may be therapeutically useful in DN, and that, podocyte apoptosis induced by HG can be reversed by PD through suppressing Drp1 expression.
Our findings provide new insights into the pathogenic process of HG‐induced podocyte injury and also identify a new therapeutic target of ROS/Drp1/mitochondrial fission/apoptosis pathway for diabetic nephropathy.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28383775</pmid><doi>10.1002/jcp.25943</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-7314-4249</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9541 |
ispartof | Journal of cellular physiology, 2017-10, Vol.232 (10), p.2776-2787 |
issn | 0021-9541 1097-4652 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5518182 |
source | Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list) |
subjects | Animals Apoptosis Apoptosis - drug effects Blood Glucose - metabolism Cell Line Cytoprotection Diabetes mellitus Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - metabolism Diabetes Mellitus, Type 2 - pathology Diabetic Nephropathies - drug therapy Diabetic Nephropathies - etiology Diabetic Nephropathies - metabolism Diabetic Nephropathies - pathology Diabetic nephropathy Disease Models, Animal Down-Regulation Dynamin Dynamins - genetics Dynamins - metabolism dynamin‐related protein 1 Fitness Glucosides - pharmacology Hyperglycemia Mice, Inbred C57BL Mitochondria Mitochondria - drug effects Mitochondria - metabolism Mitochondria - pathology Mitochondrial Dynamics - drug effects Nephropathy Original Original s Podocytes - drug effects Podocytes - metabolism Podocytes - pathology polydatin Reactive oxygen species Reactive Oxygen Species - metabolism Renal function Resveratrol Retarding RNA Interference Rodents Signal Transduction - drug effects Stilbenes - pharmacology Transfection |
title | Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A54%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polydatin%20impairs%20mitochondria%20fitness%20and%20ameliorates%20podocyte%20injury%20by%20suppressing%20Drp1%20expression&rft.jtitle=Journal%20of%20cellular%20physiology&rft.au=Ni,%20Zheng&rft.date=2017-10&rft.volume=232&rft.issue=10&rft.spage=2776&rft.epage=2787&rft.pages=2776-2787&rft.issn=0021-9541&rft.eissn=1097-4652&rft_id=info:doi/10.1002/jcp.25943&rft_dat=%3Cproquest_pubme%3E1912663436%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1912663436&rft_id=info:pmid/28383775&rfr_iscdi=true |